embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes

Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results

embecta Announces Quarterly Cash Dividend

embecta to Participate in the 11th Annual BTIG MedTech Conference

embecta to Report Fiscal First Quarter 2024 Financial Results

embecta Announces FDA 510(k) Submission for Insulin Patch Pump

embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

No embecta-made syringes impacted by FDA safety communication

embecta to Participate in Investor Conferences

Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance

embecta Announces Quarterly Cash Dividend

embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell

embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results

embecta to Participate at the Morgan Stanley 21st Annual Healthcare Conference

Embecta Corp. Reports Third Quarter Fiscal 2023 Financial Results

embecta Announces Quarterly Cash Dividend

embecta to Report Fiscal Third Quarter 2023 Financial Results

embecta to Participate in Investor Conferences

Embecta Corp. Reports Second Quarter Fiscal 2023 Financial Results

embecta and Tidepool partner to develop automated insulin delivery system for people with Type 2 diabetes

embecta Announces Quarterly Cash Dividend

embecta to Report Fiscal Second Quarter 2023 Financial Results

embecta sponsors educational symposium at ATTD 2023

Embecta Corp. Reports First Quarter Fiscal 2023 Financial Results

embecta Announces Quarterly Cash Dividend

embecta to Participate in Upcoming Investor Conferences

embecta opens new global headquarters in Parsippany, N.J.

embecta to Report Fiscal First Quarter 2023 Financial Results

Embecta Corp. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

embecta Announces Quarterly Cash Dividend

embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference

Intuity Medical and embecta Launch Commercial Collaboration, Expanding Access to Self-Management Innovations for People With Diabetes

embecta to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results

embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell

embecta to Participate in Upcoming Investor Conferences in September

Embecta Corp. Reports Third Quarter Fiscal 2022 Financial Results

embecta Announces Inaugural Quarterly Cash Dividend

embecta Announces Earnings Conference Call Information for the Third Quarter of Fiscal Year 2022

Embecta Corp. Reports Second Quarter and First Six Months of Fiscal Year 2022 Financial Results and Provides Financial Guidance for the Last Six Months of Fiscal Year 2022

embecta to Participate in Upcoming Investor Conferences in May

embecta Announces Second Quarter 2022 Earnings Conference Call Information

embecta completes spin-off from BD and lists on NASDAQ as a global leader in diabetes care

embecta to Host Virtual Investor Event Ahead of Planned Spinoff from BD

BD Board of Directors Approves embecta Spinoff and Declares Distribution of embecta Stock

BD Announces Board of Directors for embecta, the Planned Spinoff of Its Diabetes Care Business

BD Selects "embecta" as Name of New Company for Planned Spinoff of Diabetes Care Business; Announces Remainder of Leadership Team

BD Announces Two Future Directors for Diabetes Care Spinoff Company

BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets